Leap Therapeutics (LPTX) Misses Q2 EPS by 52c
Tweet
Share
E-mailGet Alerts LPTX Hot Sheet
Join SI Premium – FREE
Leap Therapeutics (NASDAQ: LPTX) reported Q2 EPS of ($0.52).
For earnings history and earnings-related data on Leap Therapeutics (LPTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Downgrades DKSH Holding AG (DKSH:SW) to Hold
- Macquarie Downgrades Tongcheng Travel Holdings Ltd (780:HK) to Neutral
- Bernstein SocGen Group Upgrades Square Enix Holdings (9684:JP) (SQNNY) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
